振江股份(603507.SH):鴻立投資及其一致行動人已減持149.8736萬股
格隆匯12月2日丨振江股份(603507.SH)公佈,公司於2021年12月2日收到公司股東:上海鴻立股權投資有限公司(“鴻立投資”或“信息披露義務人”)及其一致行動人上海鴻立華享投資合夥企業(有限合夥)(“鴻立華享”)、當塗鴻新文化產業基金(有限合夥)(“當塗鴻新”)的減持股份進展通知,彼等已合計減持149.8736萬股。
此次權益變動後,信息披露義務人及其一致行動人持有上市公司股份比例將從6.32%減少至5.19%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.